BNTC
Benitec Biopharma Ltd ADR
NASDAQ: BNTC · HEALTHCARE · BIOTECHNOLOGY
$12.05
-0.82% today
Updated 2026-04-30
Market cap
$423.73M
P/E ratio
—
P/S ratio
2,770.13x
EPS (TTM)
$-1.08
Dividend yield
—
52W range
$10 – $17
Volume
0.2M
Benitec Biopharma Ltd ADR (BNTC) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $545734.00 | $1.02M | $829127.00 | $346506.00 | $450311.00 | $455446.00 | $11.32M | $97000.00 | $59000.00 | $73000.00 | $75000.00 | $216000.00 | $0.00 |
| Revenue growth (YoY) | — | +86.5% | -18.5% | -58.2% | +30.0% | +1.1% | +2384.8% | -99.1% | -39.2% | +23.7% | +2.7% | +188.0% | -100.0% |
| Cost of revenue | $176131.00 | $37659.00 | $30680.00 | $103802.00 | $209018.00 | $331300.00 | $426506.00 | $-185000.00 | $123000.00 | $9000.00 | $381000.00 | $343000.00 | $396000.00 |
| Gross profit | $369603.00 | $980097.00 | $798447.00 | $242704.00 | $241293.00 | $124146.00 | $10.89M | $282000.00 | $-64000.00 | $64000.00 | $-306000.00 | $-343000.00 | $-396000.00 |
| Gross margin | 67.7% | 96.3% | 96.3% | 70.0% | 53.6% | 27.3% | 96.2% | 290.7% | -108.5% | 87.7% | -408.0% | -158.8% | — |
| R&D | $3.43M | $5.86M | $4.78M | $9.92M | $5.32M | $5.06M | $2.17M | $3.00M | $7.02M | $11.27M | $12.77M | $15.61M | $18.33M |
| SG&A | $4.39M | $7.67M | $6.17M | $8.96M | $6.99M | $6.41M | $6.66M | $5.57M | $6.51M | $6.65M | $6.38M | $6.71M | $23.43M |
| Operating income | $-8.16M | $-14.40M | $-13.33M | $-24.96M | $-15.92M | $-8.55M | $2.00M | $-8.28M | $-13.60M | $-17.85M | $-19.08M | $-22.60M | $-41.77M |
| Operating margin | -1494.9% | -1414.9% | -1607.6% | -7204.2% | -3536.2% | -1877.7% | 17.7% | -8537.1% | -23044.1% | -24457.5% | -25441.3% | -10462.0% | — |
| EBITDA | $-6.64M | $-9.90M | $-7.93M | $-13.42M | $-4.19M | $-8.59M | $2.74M | $-7.91M | $-13.45M | $-17.85M | $-19.15M | $-21.41M | $-41.70M |
| EBITDA margin | -1215.9% | -972.5% | -956.6% | -3872.4% | -930.5% | -1885.5% | 24.2% | -8151.5% | -22800.0% | -24457.5% | -25530.7% | -9911.1% | — |
| EBIT | $-8.16M | $-14.40M | $-8.01M | $-24.96M | $-4.36M | $-8.73M | $2.59M | $-8.28M | $-13.88M | $-18.25M | $-19.53M | $-21.75M | $-41.77M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $119057.00 | $62000.00 | $6000.00 | $32000.00 | $33000.00 | $904000.00 | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-6.42M | $-10.84M | $-8.83M | $-18.50M | $-4.37M | $-8.55M | $2.87M | $-8.27M | $-13.88M | $-18.21M | $-19.56M | $-21.75M | $-37.92M |
| Net income growth (YoY) | — | -68.7% | +18.5% | -109.6% | +76.4% | -95.6% | +133.5% | -388.6% | -67.8% | -31.2% | -7.4% | -11.2% | -74.3% |
| Profit margin | -1177.1% | -1064.7% | -1064.7% | -5340.1% | -971.0% | -1877.4% | 25.3% | -8529.9% | -23528.8% | -24942.5% | -26082.7% | -10069.9% | — |